Delineating the Mechanism of Action of the Repurposed Drug Benzatropine against Mycobacterium tuberculosis

Abstract In this study, we have performed luminescence-based screening assays and identified benzatropine, an FDA-approved drug that inhibits the intracellular growth of drug-sensitive and drug-resistant M. tuberculosis strains. We demonstrate that oral administration of benzatropine inhibits the growth of M. tuberculosis in aerosol-infected mice. Furthermore, we show that benzatropine enhances the activity of rifampicin and pretomanid against M. tuberculosis in THP-1 macrophages. Detailed analysis of the proteomics data revealed that, in comparison to the untreated and infected macrophages, the relative expression of several autophagy-related proteins was altered in benzatropine-treated and M. tuberculosis-infected macrophages. We demonstrate that exposure to benzatropine reduced phosphorylation of JAK2 and STAT3, increased intracellular ROS and calcium levels, and induced autophagy in macrophages. We further report that preincubation with histamine, wortmannin, and N-acetylcysteine reduced benzatropine’s ability to induce autophagy and inhibit the growth of intracellular bacteria. Also, activation of STAT3 signaling with colivelin and inhibition of AMPK signalling with compound C reduced benzatropine-induced autophagy. Taken together, we have shown that benzatropine, an FDA-approved drug, induces autophagy and inhibits the growth of intracellular drug-sensitive and drug-resistant M. tuberculosis.

Authors

Publication Details

Journal
ACS Infectious Diseases
Published
2026-11-13
DOI
https://doi.org/10.1021/acsinfecdis.6c00051
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Delineating the Mechanism of Action of the Repurposed Drug Benzatropine against Mycobacterium tuberculosis

Niranjana Sri Sundaramoorthy, Amit Kumar Yadav, Saurabh Chugh, Abtar Mishra et al.
2 links
ACS Infectious Diseases
Tuberculosis Research and Epidemiology
article

Delineating the Mechanism of Action of the Repurposed Drug Benzatropine against Mycobacterium tuberculosis

Niranjana Sri Sundaramoorthy, Amit Kumar Yadav, Saurabh Chugh, Abtar Mishra, Dev Kiran Nayak, Prabhakar Babele, Rohan Dhiman, Ritu Sharaya, Ramandeep Singh, Mousumi Das
article en

Abstract

Abstract In this study, we have performed luminescence-based screening assays and identified benzatropine, an FDA-approved drug that inhibits the intracellular growth of drug-sensitive and drug-resistant M. tuberculosis strains. We demonstrate that oral administration of benzatropine inhibits the growth of M. tuberculosis in aerosol-infected mice. Furthermore, we show that benzatropine enhances the activity of rifampicin and pretomanid against M. tuberculosis in THP-1 macrophages. Detailed analysis of the proteomics data revealed that, in comparison to the untreated and infected macrophages, the relative expression of several autophagy-related proteins was altered in benzatropine-treated and M. tuberculosis-infected macrophages. We demonstrate that exposure to benzatropine reduced phosphorylation of JAK2 and STAT3, increased intracellular ROS and calcium levels, and induced autophagy in macrophages. We further report that preincubation with histamine, wortmannin, and N-acetylcysteine reduced benzatropine’s ability to induce autophagy and inhibit the growth of intracellular bacteria. Also, activation of STAT3 signaling with colivelin and inhibition of AMPK signalling with compound C reduced benzatropine-induced autophagy. Taken together, we have shown that benzatropine, an FDA-approved drug, induces autophagy and inhibits the growth of intracellular drug-sensitive and drug-resistant M. tuberculosis.

ACS Infectious Diseases
Department of Biotechnology, Ministry of Science and Technology, India, Department of Science and Technology, Ministry of Science and Technology, India
Good health and well-being
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon